Glutamine supplementation for patients with severe cryptosporidiosis [6]

Clinical Infectious Diseases

Volumn 40, Issue 5, 2005, Pages 773-774

  Moling, Oswald ^a   Avi, Anna ^b   Rimenti, Giovanni ^a   Mian, Peter ^a  

^a Ospedale Generale   (Italy)

^b Ospedale Generale   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; ANTIRETROVIRUS AGENT; AZITHROMYCIN; CHLORPROMAZINE; DELORAZEPAM; DIFLUCONAZOLE; FLUCYTOSINE; GLUTAMINE; INDINAVIR; LAMIVUDINE; ONDANSETRON; PAROMOMYCIN; STAVUDINE; UNCLASSIFIED DRUG;

ADULT; CASE REPORT; CHRONIC DIARRHEA; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DIET SUPPLEMENTATION; DRUG ABSORPTION; GASTROSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; TOTAL PARENTERAL NUTRITION; VIRUS LOAD; VOMITING;

ADULT; ANTIDIARRHEALS; CRYPTOSPORIDIOSIS; DIARRHEA; GLUTAMINE; HIV INFECTIONS; HUMANS; MALE;

EID: 15044364235     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/427948     Document Type: Letter

References (3)

1. Bushen OY, Davenport JA, Bezerra Lima A, et al. Diarrhea and reduced levels of antiretroviral drugs: improvement with glutamine or alanyl-glutamine in a randomized controlled trial in northeast Brazil. Clin Infect Dis 2004; 38: 1764-70.
2. Hommer V, Eichholz J, Petry F. Effect of antiretroviral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development of Cryptosporidium parvum. J Antimicrob Chemother 2003; 52:359-64.
3. Leav BA, Mackay M, Ward HD. Cryptosporidium species: new insights and old challenges. Clin Infect Dis 2003; 36:903-8.